Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 2Breast 2

Conditions

Breast Neoplasms 2

Interventions

Trastuzumab 87Cyclophosphamide 67Capecitabine 67Paclitaxel 64Docetaxel 58Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 41Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 19atezolizumab 18pertuzumab 17Everolimus 17130-nm albumin-bound paclitaxel 17Epirubicin 16palbociclib 15Magnetic Resonance Spectroscopy 15eribulin 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Tegafur × Breast × Clear all
NCT01262274 2015-05-21

Neo-ACET BC

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Phase 2 Terminated
57 enrolled
Breast

Breast Neoplasms

NCT00005608 2012-06-06

Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer

Northwestern University

Phase 2 Terminated
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡